To assess the biological relevance of the optimized DIVA2 protocol, a prophylactic tumor experiment was performed mediating complete tumor rejection in a prophylactic tumor setting (Figure 5C) accompanied by a robust CD8 and CD4 memory response (Figure 4E). This evidence concerns the gene CD8A and neoplasm.